Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 270 entries
View as:

A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00113880 Org: User:
Start: 10/31/03 End: 06/30/10 Due: 06/30/11

Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children

Phase: N/A Priority: Normal
NCT ID: NCT00192205 Org: User:
Start: 10/31/02 End: 06/30/03 Due: 06/30/04

A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557

Phase: N/A Priority: Normal
NCT ID: NCT00578682 Org: User:
Start: 12/31/07 End: 11/30/10 Due: 11/30/11

A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)

Phase: N/A Priority: Normal
NCT ID: NCT00240929 Org: User:
Start: 09/30/02 End: 04/30/03 Due: 04/30/04

Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00069017 Org: User:
Start: 09/30/03 End: 04/30/06 Due: 04/30/07

A Phase 1/2 Study to Evaluate MEDI4736

Phase: N/A Priority: Normal
NCT ID: NCT01693562 Org: User:
Start: 09/05/12 End: 02/28/20 Due: 02/28/21

Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00192465 Org: User:
Start: 11/30/03 End: 11/30/04 Due: 11/30/05

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT03351738 Org: User:
Start: 12/13/17 End: 11/09/18 Due: 11/09/19

A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00783289 Org: User:
Start: 11/14/08 End: 11/17/09 Due: 11/17/10

Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC

Phase: N/A Priority: Normal
NCT ID: NCT04145193 Org: User:
Start: 10/01/20 End: 03/19/24 Due: 03/19/25

A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354

Phase: N/A Priority: Normal
NCT ID: NCT00638989 Org: User:
Start: 04/11/08 End: 06/07/08 Due: 06/07/09

A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00394654 Org: User:
Start: 11/30/06 End: 01/31/08 Due: 01/31/09

Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01985997 Org: User:
Start: 01/31/14 End: 07/31/14 Due: 07/31/15

A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00860067 Org: User:
Start: 03/31/09 End: 10/31/09 Due: 10/31/10

A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00538096 Org: User:
Start: 09/30/07 End: 05/31/10 Due: 05/31/11

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02118337 Org: User:
Start: 05/19/14 End: 03/17/20 Due: 03/17/21

A Study to Assess the Safety of MEDI7836 in Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT02388347 Org: User:
Start: 03/31/15 End: 04/30/16 Due: 04/30/17

A Study to Evaluate the Efficacy of MEDI7510 in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT02508194 Org: User:
Start: 09/29/15 End: 11/07/16 Due: 11/07/17

A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03946800 Org: User:
Start: 05/08/19 End: 08/24/23 Due: 08/24/24

A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01050998 Org: User:
Start: 01/05/10 End: 07/27/12 Due: 07/27/13

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02991911 Org: User:
Start: 01/06/17 End: 09/30/19 Due: 09/30/20

Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)

Phase: N/A Priority: Normal
NCT ID: NCT01475305 Org: User:
Start: 10/20/11 End: 12/13/12 Due: 12/13/13

A Sequential Dose-Escalation Study in Subjects With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00512486 Org: User:
Start: 11/30/06 End: 10/31/08 Due: 10/31/09

An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01753193 Org: User:
Start: 03/28/13 End: 07/18/18 Due: 07/18/19

A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00968669 Org: User:
Start: 12/31/09 End: 01/31/12 Due: 01/31/13